chang bullish thesi rapid rise share price us
tread cautious earn increas pt
remain enthusiast varian short-term
long-term growth potenti point top-lin margin expans opportun
well sustain underli sale instal base replac
servic contract hardwar model yet contempl growth
catalyst potenti strong uplift emerg market aggress
growth recent acquisit servic revenu grow proton
system instal base yet long-term revenu ep forecast like
conserv see slightli higher risk around earn report next
week simpli lofti investor expect often come
higher stock price share risen three month possibl
lumpi quarter quarter consensu visibl alpha
order revenu quarter particularli america oncolog gross
order growth metric face strong year-ago quarter possibl
normal quarterli volatil doesnt chang thesi believ
multipl leg growth ahead rais price target
base month non-gaap ep estim
price target previous use multipl comfort
move higher valuat multipl two reason across board
large-cap comp group multipl increas point sinc mid-decemb
model revenu compound-annual-growth-rate low end
compani outlook compound-annual-growth-rate next five year
varian fiscal first quarter model oncolog gross order
y/i vs visibl alpha consensu y/i look
flat y/i america oncolog gross order consensu metric
call y/i growth think y/i growth america order
achiev full fiscal year note tough year-ago comp y/i
growth revenu forecast y/i
consensu y/i forecast includ
revenu includ proton intervent oncolog sale consensu
estim revenu model call non-gaap ep
line consensu consid full fiscal year model
total revenu within guidanc rang forecast includ
gross oncolog order y/i non-gaap ep
top end guidanc rang consensu model
oncolog gross order y/i total revenu y/i
non-gaap ep
anticip topic earn call includ opportun china
propos radiat oncolog altern payment model market reaction
etho updat integr recent acquisit like noona
intervent oncolog asset
introduc estim model y/i sale
growth y/i growth gross order non-gaap
ep make chang forecast
valuat pt base month non-gaap ep
estim risk discuss
idc btig estim compani document
million except per share amount
varian world leader radiat therapi stereotact surgeri think offer superior technolog
faster treatment competitor rad onc market lumpi growth overal low mid-singl digit
demand halcyon product softwar offer value-ad servic drive higher growth rate
think trend continu increas order next year true spend drive
growth compani still grow ep faster peer believ deserv trade premium
final implement propos radiat oncolog altern
above-market growth oncolog gross order revenu
stabl reimburs radiat oncolog
stabl economi capital-expenditure environ
sustain resolut trade war/tariff
acceler oncolog gross order revenu growth
favor reimburs radiat oncolog
improv economi capital-expenditure environ
varian world lead
manufactur radiat therapi
brachytherapi plan
market slowdown oncolog gross order revenu growth
neg develop reimburs radiat oncolog
slump economi capital-expenditure environ
varian rate buy price target base month non-gaap ep estim varian trade
comp group feel premium warrant sinc compani revenu ep grow faster
rate comp group averag addit mid-to-long-term outlook var revenu remain conserv
manag five-year expect make higher valuat multipl palat risk rate
price target includ halcyon adopt chang oper margin capit spend slowdown hospit
govern new competit healthcar multipl gener trade lumpi quarterli result
exhibit comp tabl large-cap peer
companytickerr ptpricemarket cap bntm johnsonjnjnot pt pt bdxnot pt scientificbsxbuy pt factset data btig estimatespr ex-amortev/salescagr
varian incom oncolog total y/i good gross sg one-tim total oper incom loss invest incom pre-tax incom incom non- net incom continu net earn discont op non-control non- dilut share net ex select calendar loss net product product product oper ep ep btig estim compani report
varian revenu eoncolog gross america y/i net america order y/i gross emea y/i net emea order y/i gross apac order y/i net apac y/i gross y/i net order y/i trail month gross trail month net y/i contract y/i oncolog y/i otherproton gross y/i y/i y/i gross y/i y/i y/i btig estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
